D46 – Myelodysplastic syndromes
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Additional
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Tyoe 2 Excludes
drug-induced aplastic anemia (D61.1)
Child Codes
Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| C00-D49 | Neoplasms (C00-D49) |
| D37-D48 | Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48) |
| D46 |
Myelodysplastic syndromes
Use Additional
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Type 2 Excludes
drug-induced aplastic anemia (D61.1)
|
| D46.0 | Refractory anemia without ring sideroblasts, so stated |
| D46.1 | Refractory anemia with ring sideroblasts |
| D46.2 | Refractory anemia with excess of blasts [RAEB] |
| D46.20 | Refractory anemia with excess of blasts, unspecified |
| D46.21 | Refractory anemia with excess of blasts 1 |
| D46.22 | Refractory anemia with excess of blasts 2 |
| D46.A | Refractory cytopenia with multilineage dysplasia |
| D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| D46.C | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
| D46.4 | Refractory anemia, unspecified |
| D46.Z | Other myelodysplastic syndromes |
| D46.9 | Myelodysplastic syndrome, unspecified |